Clinicopathological Variables | All | Genotype(%) | A allele frequency | Adjusteda | ||
---|---|---|---|---|---|---|
GG | GA+AA | P | OR (95 % CI) | |||
Age | 308 | Â | 0.948 | Â | ||
< 52 | 118 | 88 (74.6) | 30 (25.4) | 0.136 | 1.00 (ref) | |
≥52 | 190 | 146 (76.8) | 44 (23.2) | 0.137 | 2.87 (0.93-5.84) | |
Clinical stage | 300 | Â | Â | Â | 0.474 | Â |
I-II | 92 | 69 (75.0) | 23 (25.0) | 0.131 | 1.00 (ref) | |
III-IV | 208 | 158 (76.0) | 50 (24.0) | 0.142 | 1.30 (0.89-1.93) | |
Tumor histology | 308 | Â | 0.003 | Â | ||
Serous | 196 | 150 (76.5) | 46 (23.5) | 0.128 | Â | 1.00 (ref) |
Mucinous | 24 | 15 (62.5) | 9 (37.5) | 0.250 | 0.001 | 3.48 (1.15-6.83) |
Endometrioid | 22 | 17 (77.3) | 5 (22.7) | 0.114 | 0.337 | 2.25 (0.96-4.44) |
Mixed/other | 66 | 52 (78.8) | 14 (21.2) | 0.136 | 0.597 | 0.93 (0.76-1.19) |
Degree of differentiation | 246 | Â | 0.005 | Â | ||
High | 28 | 22 (78.6) | 6 (21.4) | 0.107 | Â | 1.00 (ref) |
Medium | 82 | 65 (79.3) | 17 (20.7) | 0.104 | 0.827 | 1.15 (0.86-1.69) |
Low | 136 | 98 (72.1) | 38 (27.9) | 0.162 | 0.003 | 1.87 (1.03-3.47) |
Tumor behavior | 294 | Â | 0.838 | Â | ||
Borderline | 48 | 37 (77.1) | 11 (22.9) | 0.125 | 1.00 (ref) | |
Invasive | 246 | 191 (77.6) | 55 (22.4) | 0.122 | 0.91 (0.79-1.03) | |
Lymph node statusb | 176 | Â | 0.010 | Â | ||
Negative | 62 | 50 (80.6) | 12 (19.4) | 0.105 | 1.00 (ref) | |
Positive | 114 | 83 (72.8) | 31 (27.2) | 0.154 | 1.69 (1.14-2.75) | |
ERc | 183 | Â | 0.002 | Â | ||
Negative | 42 | 36 (85.7) | 6 (14.3) | 0.095 | 1.00 (ref) | |
Positive | 141 | 100 (70.9) | 41 (29.1) | 0.163 | 2.72 (1.38-4.81) | |
PRc | 171 | Â | 0.329 | Â | ||
Negative | 66 | 49 (74.2) | 17 (25.8) | 0.144 | Â | 1.00 (ref) |
Positive | 105 | 81 (77.1) | 24 (22.9) | 0.129 | Â | 1.43 (0.76-2.32) |